Literature DB >> 2833567

Ultrastructural distribution of the major capsid proteins within bluetongue virus and infected cells.

A D Hyatt1, B T Eaton.   

Abstract

Core proteins VP7 and VP3 have been localized in bluetongue virus (BTV) and BTV-infected cells by immunoelectron microscopy. Gold-labelled monoclonal antibodies to VP7 gave intense labelling with purified BTV core particles and weaker labelling with both directly visualized viral particles, which require no purification, and purified virus particles. It is believed that VP7 is, in a small number of viruses, accessible from the outer surface. The intensity of labelling by anti-VP7 antibodies was markedly increased by treatment of the virus with methanol. Intracellularly, VP7 antibodies also reacted with virus-like particles which appeared to be leaving virus inclusion bodies (VIB), the presumed site of virus synthesis and assembly. These antibodies also reacted with virus-like particles which were bound to the cytoskeleton and did not appear to be virus cores because they also reacted with gold-labelled antibody to the outer coat protein VP2. VP3 was not detected immunologically in either virus or core particles nor in cytoskeleton-associated virus-like particles suggesting an inner core location. VP7 and to a lesser extent VP3 were localized within the matrix of VIB. Virus tubules, a major structure found in infected cells and known to contain the non-structural protein NS1, were found to react with antibodies to both VP3 and VP7.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833567     DOI: 10.1099/0022-1317-69-4-805

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  Localization of the single-stranded RNA-binding domains of bluetongue virus nonstructural protein NS2.

Authors:  G C Fillmore; H Lin; J K K Li
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Three-dimensional structure of single-shelled bluetongue virus.

Authors:  B V Prasad; S Yamaguchi; P Roy
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  A second form of infectious bursal disease virus-associated tubule contains VP4.

Authors:  H Granzow; C Birghan; T C Mettenleiter; J Beyer; B Köllner; E Mundt
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates.

Authors:  N Stäuber; J Martinez-Costas; G Sutton; K Monastyrskaya; P Roy
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Site-specific mutations in the NS2 protein of epizootic haemorrhagic disease virus markedly affect the formation of cytoplasmic inclusion bodies.

Authors:  J Theron; H Huismans; L H Nel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Topography and immunogenicity of bluetongue virus VP7 epitopes.

Authors:  L F Wang; A D Hyatt; P L Whiteley; M Andrew; J K Li; B T Eaton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.

Authors:  Andrew R Beaton; Javier Rodriguez; Y Krishnamohan Reddy; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

8.  Assembly and intracellular localization of the bluetongue virus core protein VP3.

Authors:  Alak Kanti Kar; Nao Iwatani; Polly Roy
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

Authors:  M Cloete; D H du Plessis; A A van Dijk; H Huismans; G J Viljoen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Synthesis and characterization of chimeric particles between epizootic hemorrhagic disease virus and bluetongue virus: functional domains are conserved on the VP3 protein.

Authors:  H Le Blois; B Fayard; T Urakawa; P Roy
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.